Rainbow Crops Awarded $7 Million Grant to Advance Climate-Resilient Crops

Ghent, Belgium - 4 March 2026 - Rainbow Crops, a next-generation agtech company developing crop genetics with enhanced complex agronomic traits, has been awarded a $7 million grant from the Gates Foundation. The funding will support the application of Rainbow Crops’ Trait Foundry™ platform to advance new genetic approaches for improving crop performance under heat and drought stress to meet the needs of smallholder farmers.

With the aim of progressing climate-resilient crops and improved germplasm delivery, the platform will develop innovative approaches for identifying and combining alleles to support germination under challenging climatic conditions.

Rainbow Crops’ Trait Foundry™ platform integrates multiplex genome editing, AI, breeding, and phenotyping to enable the systematic identification and combination of optimized genetic variants underlying complex agronomic traits. Unlike traditional breeding or single-gene approaches, the platform is designed to address traits controlled by multiple interacting genes, such as drought tolerance and plant vigor.

The research will initially focus on corn, sorghum, and rice - crops that are important to global food security, particularly in Sub-Saharan Africa and South Asia. The project places a strong emphasis on seedling performance under heat and drought stress, generating both scientific knowledge and trait-building blocks that can support future breeding efforts.

Rainbow Crops’ technology platform builds on years of research at VIB, a leading life sciences research institute, where the underlying scientific work was developed. As part of this collaboration, Rainbow Crops will work with the Lab of Professor Hilde Nelissen, from which Rainbow Crops was spun off, as well as with the VIB Transformation Facility & VIB Agro-Incubator.

Giacomo Bastianelli, Co-founder and CEO of Rainbow Crops, said, “This grant allows us to further strengthen our technology platform and contribute foundational advances that enable more climate-resilient crops, with relevance to regions most vulnerable to environmental change.”

The platform has already been validated end-to-end in corn, demonstrating the feasibility of Rainbow Crops’ multiplex genome editing and discovery approach across multiple traits. In addition, Rainbow Crops will collaborate with other industry partners, including coordination on scientific approaches and data sharing to accelerate collective progress.

 

About Rainbow Crops

Rainbow Crops is a next-generation agtech company developing climate-resilient, high-performing crop varieties through its proprietary Trait Foundry™ platform. By integrating multiplex genome editing, artificial intelligence, precision breeding, and automated phenotyping, Rainbow Crops enables the systematic engineering of complex agronomic traits. The company collaborates with seed and breeding partners to advance sustainable agriculture and global food security. Founded in 2025 as a spin-off from the VIB–UGent Center for Plant Systems Biology, Rainbow Crops builds on years of publicly supported research and operates within VIB’s advanced research infrastructure.

Learn more at www.rainbowcrops.com

 

 

 

 

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be